Teva Pharmaceutical Industries Gross Margin 2010-2024 | TEVA

Teva Pharmaceutical Industries gross margin for the quarter ending December 31, 2024 was 48.74%.

  • Teva Pharmaceutical Industries average gross margin for 2023 was 46.29%, a 2.73% increase from 2022.
  • Teva Pharmaceutical Industries average gross margin for 2022 was 47.59%, a 1.36% decline from 2021.
  • Teva Pharmaceutical Industries average gross margin for 2021 was 46.95%, a 2.71% increase from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M